Nav: Home

Cervical cancer survivors suffer from fatigue, insomnia and hot flushes

May 04, 2017

Vienna Austria: Around half of women who have been treated for locally advanced cervical cancer suffer from symptoms of insomnia, fatigue or hot flushes at some point, according to new research presented at the ESTRO 36 conference.

Cervical cancer affects more than 500,000 women around the world each year [1], with an average age at diagnosis of 50. Survival rates, even in women where the cancer has begun to spread to nearby tissue, have increased [2] meaning women are living with side-effects for longer.

Dr Stéphanie Smet, a resident in radiation oncology at the Medical University of Vienna, Austria, who presented the research, says that these symptoms may have a substantial impact on patients' daily lives and they need to be better recognised and treated when necessary.

The study [3] involved 1,176 patients with locally advanced cervical cancer, treated at 22 centres around the world between 2008 and 2015. All received the gold-standard treatment of radiotherapy combined with chemotherapy, followed by brachytherapy, where an MRI scanner is used to guide a radioactive implant to the site of the cancer to deliver a high dose of radiotherapy. Patients were followed up for an average of 27 months.

They were assessed for symptoms by their doctors and filled in questionnaires themselves. The results show that 64% of women were experiencing fatigue to some degree at least once during their regular follow-up examinations in the years after treatment. For insomnia, the figure was 43% and for hot flushes it was 50%. These symptoms were mainly in the mild to moderate range. Severe or disabling symptoms were rare at 4%, 3% and 2% respectively.

Patients were on average 49 years old, ranging from 22 to 91, and the results show that younger women were more likely to experience these symptoms.

Dr Smet told the congress: "Our study shows that around half of women with locally advanced cervical cancer are, at some point, suffering from mild to moderate fatigue, insomnia and hot flushes. These symptoms could have a serious impact on patients' daily life, possibly influencing how they feel in their professional, social and family life.

"More and more women diagnosed with this type of cancer are surviving for longer, thanks to advances in radiotherapy. This is a relatively young group of patients, so many will possibly face decades of coping with their symptoms.

"It is important to realise that these symptoms can already exist before patients start the treatment, sometimes even before they are diagnosed with cancer. It is difficult to distinguish whether and to what extent these symptoms are caused by the cancer itself, by the treatment or by other factors. In most cases, it is probably a combination."

Until now, research in this area of radiotherapy has primarily focused on symptoms related to nearby organs at risk such as the bladder, bowel, rectum or vagina. Dr Smet continued: "We hope that by presenting our report we will create more awareness for these under-recognised symptoms.

"There has been a great deal of research on treating cancer-related fatigue and insomnia, and treatment options include drugs, physical exercise and psychological counselling. Hormone replacement therapy can be a safe and effective treatment for hot flushes, if it administered as soon as the menopause begins and for a period of four to five years."

Dr Smet told the congress that more work is needed to decipher which patients are most at risk of developing these symptoms and to tailor support accordingly.

She also said that the study could help understand the symptoms experienced by other cancer patients who are treated with pelvic radiotherapy. This includes other gynaecological cancers as well as rectal and prostate cancer.

President of ESTRO, Professor Yolande Lievens, head of the department of radiation oncology at Ghent University Hospital, Belgium, said: "Thanks to advances in treatment, cancer survival is improving, which makes us aware of the fact that besides the loco-regional side effects we are typically focusing on, we should also be vigilant for more general side effects. These results highlight how important it is to follow cancer survivors in the long term. Medical teams who look after patients treated for cancer of the cervix, and by extension other gynaecologic and pelvic cancers, need to be aware of symptoms such as fatigue, insomnia and hot flushes, and be able to advise on management and treatment options."
-end-


European Society for Radiotherapy and Oncology (ESTRO)

Related Cancer Articles:

Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Cancer genomics continued: Triple negative breast cancer and cancer immunotherapy
Continuing PLOS Medicine's special issue on cancer genomics, Christos Hatzis of Yale University, New Haven, Conn., USA and colleagues describe a new subtype of triple negative breast cancer that may be more amenable to treatment than other cases of this difficult-to-treat disease.
Metabolite that promotes cancer cell transformation and colorectal cancer spread identified
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
UH Cancer Center researcher finds new driver of an aggressive form of brain cancer
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.
UH Cancer Center researchers develop algorithm to find precise cancer treatments
University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze 'Big Data' obtained from tumor samples to better understand and treat cancer.
New analytical technology to quantify anti-cancer drugs inside cancer cells
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer.
Cancer expert says public health and prevention measures are key to defeating cancer
Is investment in research to develop new treatments the best approach to controlling cancer?
UI Cancer Center, Governors State to address cancer disparities in south suburbs
The University of Illinois Cancer Center and Governors State University have received a joint four-year, $1.5 million grant from the National Cancer Institute to help both institutions conduct community-based research to reduce cancer-related health disparities in Chicago's south suburbs.
Leading cancer research organizations to host international cancer immunotherapy conference
The Cancer Research Institute, the Association for Cancer Immunotherapy, the European Academy of Tumor Immunology, and the American Association for Cancer Research will join forces to sponsor the first International Cancer Immunotherapy Conference at the Sheraton New York Times Square Hotel in New York, Sept.

Related Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Anthropomorphic
Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#532 A Class Conversation
This week we take a look at the sociology of class. What factors create and impact class? How do we try and study it? How does class play out differently in different countries like the US and the UK? How does it impact the political system? We talk with Daniel Laurison, Assistant Professor of Sociology at Swarthmore College and coauthor of the book "The Class Ceiling: Why it Pays to be Privileged", about class and its impacts on people and our systems.